Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
phenazopyridine
- Development stage
- Phase 4
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Phenazopyridine is a small molecule urinary tract analgesic used to relieve pain, burning, irritation, urgency, and frequency associated with irritation of the lower urinary tract mucosa caused by infection (such as urinary tract infections), trauma, surgery, endoscopic procedures, or catheter use. It does not treat the underlying cause of symptoms (e.g., it is not an antibiotic) but provides symptomatic relief. The drug is an azo dye that exerts a direct topical analgesic effect on the mucosa lining of the urinary tract after being rapidly excreted into urine by the kidneys. Its precise mechanism of action remains unclear but is believed to involve local anesthetic effects on the urothelium[1][2][3][4][5][6].
- Brand names
- AZO Urinary Pain ReliefAZO Urinary Pain Relief Max StrengthAzo-StandardBaridiumProdiumPyridiatePyridiumUristatUricalmUrodineUrogesicNefrecilNexurinPhenazalginPhenazoPhenazodinePyridium PlusUropyrineUrovitSedural
- Other names
- phenazopyridine hydrochloride
02
Targets
ANKK1 (Ankyrin repeat and kinase domain containing protein 1)GAK (Cyclin G-associated kinase)DYRK2 (Dual-specificity tyrosine-phosphorylation-regulated kinase 2)MKNK2 (MAP kinase-interacting serine/threonine-protein kinase 2)PI4KB (Phosphatidylinositol 4-kinase beta)PIP4K2C (Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma)RIOK2 (Right open reading frame kinase 2)TYK2 (Tyrosine kinase 2)
Beyond the preview
Go deeper on phenazopyridine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on phenazopyridine.